Related references
Note: Only part of the references are listed.Multiple sclerosis presented as clinically isolated syndrome: the need for early diagnosis and treatment
Sotirios Giannopoulos
Therapeutics and Clinical Risk Management (2016)
Cerebrospinal fluid/serum gradient of IgG is associated with disability at acute attacks of neuromyelitis optica
Sung-Min Kim et al.
JOURNAL OF NEUROLOGY (2011)
Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis
J. Kuhle et al.
NEUROLOGY (2011)
Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis
N. Mattsson et al.
MULTIPLE SCLEROSIS JOURNAL (2009)
Biological markers for axonal degeneration in CSF and blood of patients with the first event indicative for multiple sclerosis
Katharina Hein (nee Maier) et al.
NEUROSCIENCE LETTERS (2008)
Sodium channel expression within chronic multiple sclerosis plaques
Joel A. Black et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2007)
Transient axonal injury in the absence of demyelination:: A correlate of clinical disease in acute experimental autoimmune encephalomyelitis
F Aboul-Enein et al.
ACTA NEUROPATHOLOGICA (2006)
Revised diagnostic criteria for neuromyelitis optica
D. M. Wingerchuk et al.
NEUROLOGY (2006)
Diagnostic criteria for multiple sclerosis: 2005 Revisions to the McDonald Criteria
CH Polman et al.
ANNALS OF NEUROLOGY (2005)
Effects of chronic glucocorticoid administration on insulin-degrading enzyme and amyloid-beta peptide in the aged macaque
JJ Kulstad et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2005)
The effect of simvastatin treatment on the amyloid precursor protein and brain cholesterol metabolism in patients with Alzheimer's disease
K Hoglund et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2005)
Plasma levels of β-amyloid(1-40), β-amyloid(1-42), and total β-amyloid remain unaffected in adult patients with hypercholesterolemia after treatment with statins
K Höglund et al.
ARCHIVES OF NEUROLOGY (2004)
Co-localization of sodium channel Nav1.6 and the sodium-calcium exchanger at sites of axonal injury in the spinal cord in EAE
MJ Craner et al.
BRAIN (2004)
Decreased levels of soluble amyloid beta-protein precursor and beta-amyloid protein in cerebrospinal fluid of patients with systemic lupus erythematosus
E Trysberg et al.
ARTHRITIS RESEARCH & THERAPY (2004)
Measurement of α- and β-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients
A Olsson et al.
EXPERIMENTAL NEUROLOGY (2003)
Evidence that nonsteroidal anti-inflammatory drugs decrease amyloid β42 production by direct modulation of γ-secretase activity
S Weggen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory
PR Turner et al.
PROGRESS IN NEUROBIOLOGY (2003)
Treatment with simvastatin in patients with Alzheimer's disease lowers both alpha- and beta-cleaved amyloid precursor protein
M Sjogren et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2003)
Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time
T Kuhlmann et al.
BRAIN (2002)
Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease:: A 26-week randomized, placebo-controlled, double-blind trial
M Simons et al.
ANNALS OF NEUROLOGY (2002)
Prednisolone (30-60 mg/day) for diseases other than AD decreases amyloid β-peptides in CSF
T Tokuda et al.
NEUROLOGY (2002)
Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo
K Fassbender et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Demyelination and axonal damage in a non-human primate model of multiple sclerosis
G Mancardi et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2001)
A longitudinal study of callosal atrophy and interhemispheric dysfunction in relapsing-remitting multiple sclerosis
J Pelletier et al.
ARCHIVES OF NEUROLOGY (2001)
Relationship between brain atrophy and disability: an 8-year follow-up study of multiple sclerosis patients
E Fisher et al.
MULTIPLE SCLEROSIS (2000)
Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors
B Wolozin et al.
ARCHIVES OF NEUROLOGY (2000)
Multiple sclerosis and chronic autoimmune encephalomyelitis -: A comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions
B Kornek et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Acute axonal injury in multiple sclerosis -: Correlation with demyelination and inflammation
A Bitsch et al.
BRAIN (2000)
Axonal membrane proteins are transported in distinct carriers: A two-color video microscopy study in cultured hippocampal neurons
C Kaether et al.
MOLECULAR BIOLOGY OF THE CELL (2000)
Levels of α- and β-secretase cleaved amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients
K Sennvik et al.
NEUROSCIENCE LETTERS (2000)
Share Paper
